P. La-protéine, a) Expression de la protéine P16, p.65

J. Monsonego, Traité des infections et pathologies génitales à papillomavirus. Paris; 2007. 2. l'ADF Cddmd. Le chirurgien-dentiste face au cancer. Du diagnostic précoce du cancer buccal à la prise en charge du patient cancéreux, 2008.
DOI : 10.1007/978-2-287-72066-6

R. Kuffer, . Lt, C. Husson-bui, B. Courrier, and J. Samson, La muqueuse buccale: de la clinique au traitement, 2009.

C. Larbouret, B. Robert, I. Teulon, D. Azria, and A. Pèlegrin, Association d???anticorps anti-EGFR et anti-HER2, m??decine/sciences, vol.23, issue.10, 2008.
DOI : 10.1051/medsci/20072310800

URL : http://www.medecinesciences.org/articles/medsci/pdf/2007/11/medsci20072310p800.pdf

D. Gauzeran, Lésions à risque et cancers de la bouche. Editions CdP ed. Paris, 2007.

J. Brugere, P. Guenel, A. Leclerc, and J. Rodriguez, Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth, Cancer, vol.55, issue.2, pp.391-396, 1986.
DOI : 10.1002/1097-0142(19860115)57:2<391::AID-CNCR2820570235>3.0.CO;2-Q

A. Hong, A. Grulich, and D. Jones, Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets, Vaccine, vol.28, issue.19, pp.3269-72, 2019.
DOI : 10.1016/j.vaccine.2010.02.098

K. Hannisdal, A. Schjolberg, D. Angelis, P. Boysen, M. Clausen et al., Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway, Acta Oto-Laryngologica, vol.9, issue.2, pp.293-302
DOI : 10.1034/j.1600-0714.2000.290405.x

A. Antonsson, D. Nancarrow, and I. Brown, High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.8, pp.2080-2087
DOI : 10.1158/1055-9965.EPI-10-0033

J. Samson, . Dd, and J. Carrel, Lésions précancéreuses et précurseurs du carcinome épidermoïde de la cavité buccale, Réal Clin, vol.10, pp.373-87, 1999.

B. Slama, Panorama des principales affections de la muqueuse buccale Aventis ed; 2003. 14. Lucas, Pathology of tumors of the oral tissues, p.95, 1976.

J. Muhlstein, Thèse : Médecins et patientes face à l'arrivée du vaccin prophylacique quadrivalent pour la prévention du cancer du col utérin

J. Walboomers, M. Jacobs, and M. Manos, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, The Journal of Pathology, vol.89, issue.1, pp.12-21, 1999.
DOI : 10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T

F. Bosch, A. Lorincz, N. Munoz, C. Meijer, and K. Shah, The causal relation between human papillomavirus and cervical cancer, Journal of Clinical Pathology, vol.55, issue.4, pp.244-65, 2002.
DOI : 10.1136/jcp.55.4.244

F. Bosch and N. Munoz, The viral etiology of cervical cancer, Virus Research, vol.89, issue.2, pp.183-90, 2002.
DOI : 10.1016/S0168-1702(02)00187-9

N. Munoz, Human papillomavirus and cancer: the epidemiological evidence, Journal of Clinical Virology, vol.19, issue.1-2, pp.1-5, 2000.
DOI : 10.1016/S1386-6532(00)00125-6

J. Muhlstein, Médecins et patientes face à l'arrivée du vaccin prophylacique quadrivalent pour la prévention du cancer du col utérin

C. Pochet and . Gc, Bio-images Accessed, 2007.

D. Solomon, D. Davey, and R. Kuman, The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology, Obstetrical & Gynecological Survey, vol.57, issue.8, pp.2114-2123, 2002.
DOI : 10.1097/00006254-200208000-00015

J. Monsonego and R. Richart, Infections à papillomavirus -Etat des connaissances, pratiques et prévention vaccinale Human Papillomavirus DNA testing as an adjunct to cytology in cervical screening programs, Arch Pathol Lab Med, vol.127, 2003.

S. Jolly, P. Pinon, and M. Ottman, Présentation générale de la famille des Papillomaviridae

N. Munoz, F. Bosch, and S. De-sanjose, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med Feb, vol.6348, issue.6, pp.518-545, 2003.

S. Kyo, M. Inoue, M. Koyama, M. Fujita, O. Tanizawa et al., Detection Of High-Risk Human Papillomavirus In The Cervix And Semen Of Sex Partners, Journal of Infectious Diseases, vol.170, issue.3, 1994.
DOI : 10.1093/infdis/170.3.682

N. Gavillon, H. Vervaet, E. Derniaux, P. Terrosi, O. Graesslin et al., Papillomavirus humain (HPV)??: comment ai-je attrap?? ??a???, Gyn??cologie Obst??trique & Fertilit??, vol.38, issue.3, pp.199-204
DOI : 10.1016/j.gyobfe.2010.01.003

M. Bleeker, J. Berkhof, and C. Hogewoning, HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions, British Journal of Cancer, vol.75, issue.8, pp.1388-92, 2005.
DOI : 10.1136/sti.75.5.312

M. Bleeker, C. Hogewoning, and J. Berkhof, Concordance of Specific Human Papillomavirus Types in Sex Partners Is More Prevalent than Would Be Expected by Chance and Is Associated with Increased Viral Loads, Clinical Infectious Diseases, vol.1, issue.2, pp.612-632, 2005.
DOI : 10.1093/jnlids/176.2.353

R. Haddad, C. Crum, and Z. Chen, HPV16 transmission between a couple with HPV-related head and neck cancer, Oral Oncology, vol.44, issue.8, pp.812-817, 2008.
DOI : 10.1016/j.oraloncology.2007.09.004

H. Hausen, Infections causing human cancer. Wiley-VCH ed. Heidelberg, 2006.

R. Winer, S. Lee, J. Hughes, D. Adam, N. Kiviat et al., Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students, American Journal of Epidemiology, vol.157, issue.3, pp.218-244, 2003.
DOI : 10.1093/aje/kwf180

R. Moy, Y. Eliezri, G. Nuovo, J. Zitelli, R. Bennett et al., Human papillomavirus type 16 DNA in periungual squamous cell carcinomas, JAMA, 1989.

C. Worda, A. Huber, and G. Hudelist, Prevalence of Cervical and Intrauterine Human Papillomavirus Infected in the Third Trimester in Asymptomatic Women, Journal of the Society for Gynecologic Investigation, vol.81, issue.6, pp.440-444, 2005.
DOI : 10.1016/j.fertnstert.2003.08.020

X. Castellsague, T. Drudis, and M. Canadas, Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain, BMC Infectious Diseases, vol.60, issue.Suppl 1, p.74, 2009.
DOI : 10.1006/gyno.1996.0055

E. Hajek, Contribution to the Etiology of Laryngeal Papilloma in Children, The Journal of Laryngology & Otology, vol.5, issue.03, pp.166-174, 1956.
DOI : 10.1288/00005537-195110000-00005

C. Bergeron, A. Ferenczy, and R. Richart, Underwear: Contamination by human papillomaviruses, American Journal of Obstetrics and Gynecology, vol.162, issue.1, pp.25-34, 1990.
DOI : 10.1016/0002-9378(90)90813-M

M. Zhao, E. Rosenbaum, and A. Carvalho, Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer, International Journal of Cancer, vol.39, issue.4, pp.605-615, 2005.
DOI : 10.1016/S0002-9440(10)63871-0

A. Ferenczy, C. Bergeron, and R. Richart, Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections, International Journal of Gynecology & Obstetrics, vol.32, issue.3, pp.950-954, 1989.
DOI : 10.1016/0020-7292(90)90371-Q

H. Hz, Infections causing human cancer. Wiley-VCH ed. Heidelberg, 2006.

L. Calero and T. Brusis, Laryngeal papillomatosis -first recognition in Germany as an occupational disease in an operating room nurse, Laryngorhinootologie, vol.82, issue.11, pp.790-793, 2003.

L. Bousarghin, A. Touze, P. Sizaret, and P. Coursaget, Human Papillomavirus Types 16, 31, and 58 Use Different Endocytosis Pathways To Enter Cells, Journal of Virology, vol.77, issue.6, pp.3846-50, 2003.
DOI : 10.1128/JVI.77.6.3846-3850.2003

URL : http://jvi.asm.org/content/77/6/3846.full.pdf

T. Giroglou, L. Florin, F. Schafer, R. Streeck, and M. Sapp, Human Papillomavirus Infection Requires Cell Surface Heparan Sulfate, Journal of Virology, vol.75, issue.3, pp.1565-70, 2001.
DOI : 10.1128/JVI.75.3.1565-1570.2001

URL : http://jvi.asm.org/content/75/3/1565.full.pdf

L. Bousarghin, A. Touze, A. Combita-rojas, and P. Coursaget, Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor, Journal of General Virology, vol.84, issue.1, pp.157-64, 2003.
DOI : 10.1099/vir.0.18789-0

V. Laniosz, S. Dabydeen, M. Havens, and P. Meneses, Human Papillomavirus Type 16 Infection of Human Keratinocytes Requires Clathrin and Caveolin-1 and Is Brefeldin A Sensitive, Journal of Virology, vol.83, issue.16, pp.8221-8253, 2009.
DOI : 10.1128/JVI.00576-09

S. Morse, R. Ballard, K. Holmes, and A. Moreland, Genital human papillomavirus infections. Atlas of sexually transmitted deases and AIDS, pp.261-78, 2003.

E. Franco and D. Harper, Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control, Vaccine, vol.23, issue.17-18, pp.17-182388, 2005.
DOI : 10.1016/j.vaccine.2005.01.016

L. Villa, R. Costa, and C. Petta, High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up, British Journal of Cancer, vol.157, issue.11, pp.1459-66, 2006.
DOI : 10.1093/aje/kwf180

B. Zhang, W. Chen, and A. Roman, The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation, Proceedings of the National Academy of Sciences, vol.329, issue.1, pp.437-479, 2006.
DOI : 10.1016/j.virol.2004.08.009

S. Titolo, K. Brault, J. Majewski, P. White, and J. Archambault, Characterization of the Minimal DNA Binding Domain of the Human Papillomavirus E1 Helicase: Fluorescence Anisotropy Studies and Characterization of a Dimerization-Defective Mutant Protein, Journal of Virology, vol.77, issue.9, pp.5178-91, 2003.
DOI : 10.1128/JVI.77.9.5178-5191.2003

C. Bergeron, La protéine P16: un marqueur cytologique des néoplasies intraépithéliales du col utérin? Ann Pathol, pp.1543-1587, 2007.
DOI : 10.1016/s0242-6498(07)92854-0

P. Weinberger, M. Merkley, and S. Khichi, Human papillomavirus-active head and neck cancer and ethnic health disparities, The Laryngoscope, vol.12, issue.suppl 8, pp.1531-1538, 2007.
DOI : 10.1097/01.AOG.0000266984.23445.9c

URL : http://europepmc.org/articles/pmc3051373?pdf=render

R. Gupta, R. Srinivasan, R. Nijhawan, V. Suri, and R. Uppal, Protein p 16INK4A expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of uterine cervix, Indian J Pathol Microbiol, vol.53, issue.1, pp.7-11

I. Frazer, R. Thomas, and J. Zhou, Potential strategies utilised by papillomavirus to evade host immunity, Immunological Reviews, vol.20, issue.1, pp.131-173, 1999.
DOI : 10.1084/jem.187.10.1549

A. Agarossi, E. Casolati, and M. Valieri, Mucosal immune response to Human Papilloma Virus (HPV) infection in HIV positive women, 2003.

J. Boulanger, H. Sevestre, E. Bauville, C. Ghighi, J. Harlicot et al., ??pid??miologie de l???infection ?? HPV, Gyn??cologie Obst??trique & Fertilit??, vol.32, issue.3, pp.218-241, 2004.
DOI : 10.1016/j.gyobfe.2004.01.013

A. Moscicki, S. Shiboski, and N. Hills, Regression of low-grade squamous intra-epithelial lesions in young women, The Lancet, vol.364, issue.9446, pp.1678-83, 2004.
DOI : 10.1016/S0140-6736(04)17354-6

V. Dalstein, D. Riethmuller, and J. Pretet, Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study, International Journal of Cancer, vol.91, issue.3, pp.396-403, 2003.
DOI : 10.1093/jnci/91.3.252

G. Ho, Y. Studentsov, and C. Hall, Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV???16 Virus???Like Particles, The Journal of Infectious Diseases, vol.186, issue.6, pp.737-779, 2002.
DOI : 10.1086/342972

C. Woodman, S. Collins, and L. Young, The natural history of cervical HPV infection: unresolved issues, Nature Reviews Cancer, vol.55, issue.Suppl. 3, pp.11-22, 2007.
DOI : 10.1136/gut.2005.077776

A. Moscicki, GENITAL INFECTIONS WITH HUMAN PAPILLOMAVIRUS (HPV), The Pediatric Infectious Disease Journal, vol.17, issue.7, pp.651-653, 1998.
DOI : 10.1097/00006454-199807000-00014

Z. Sun, Y. Ji, W. Zhou, S. Zhang, W. Jiang et al., Characteristics of HPV prevalence among women in Liaoning province, China, International Journal of Gynecology & Obstetrics, vol.367, issue.9518
DOI : 10.1016/S0140-6736(06)68439-0

G. Ho, R. Bierman, L. Beardsley, C. Chang, and R. Burk, Natural History of Cervicovaginal Papillomavirus Infection in Young Women, New England Journal of Medicine, vol.338, issue.7, pp.423-431, 1998.
DOI : 10.1056/NEJM199802123380703

M. Stanley, HPV: immune response to infection and vaccination. Infect Agent Cancer, Oct, vol.205, issue.1, p.19
DOI : 10.1186/1750-9378-5-19

URL : https://infectagentscancer.biomedcentral.com/track/pdf/10.1186/1750-9378-5-19?site=infectagentscancer.biomedcentral.com

M. Pett, M. Herdman, and R. Palmer, Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response, Proceedings of the National Academy of Sciences, vol.125, issue.1-2, pp.3822-3829, 2006.
DOI : 10.1016/S0166-4328(01)00297-2

S. Kanodia, L. Fahey, and W. Kast, Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets, Feb, vol.7, issue.1, pp.79-89, 2007.

U. Hasan, E. Bates, and F. Takeshita, TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16, The Journal of Immunology, vol.178, issue.5, 2007.
DOI : 10.4049/jimmunol.178.5.3186

F. Stubenrauch, M. Hummel, T. Iftner, and L. Laimins, The E8^E2C Protein, a Negative Regulator of Viral Transcription and Replication, Is Required for Extrachromosomal Maintenance of Human Papillomavirus Type 31 in Keratinocytes, Journal of Virology, vol.74, issue.3, pp.1178-86, 2000.
DOI : 10.1128/JVI.74.3.1178-1186.2000

X. Carcopino, M. Henry, D. Olive, L. Boubli, and C. Tamalet, [Detection and quantification of human papillomavirus genital infections: Virological, epidemiological, and clinical applications, Med Mal Infect

M. Cricca, A. Morselli-labate, and S. Venturoli, Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions, Gynecologic Oncology, vol.106, issue.3, pp.549-57, 2007.
DOI : 10.1016/j.ygyno.2007.05.004

J. Cuzick, Role of HPV testing in clinical practice, Virus Research, vol.89, issue.2, pp.263-272, 2002.
DOI : 10.1016/S0168-1702(02)00194-6

A. Fiander, K. Hart, and S. Hibbitts, Variation in human papillomavirus type-16 viral load within different histological grades of cervical neoplasia, Journal of Medical Virology, vol.54, issue.9, 2007.
DOI : 10.1007/978-3-642-78487-3_4

J. Zhou, X. Sun, D. Stenzel, and I. Frazer, Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles, Virology, vol.185, issue.1, pp.251-258, 1991.
DOI : 10.1016/0042-6822(91)90772-4

R. Kirnbauer, F. Booy, N. Cheng, D. Lowy, and J. Schiller, Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic., Proceedings of the National Academy of Sciences, vol.89, issue.24
DOI : 10.1073/pnas.89.24.12180

URL : http://www.pnas.org/content/89/24/12180.full.pdf

F. Breitburd, R. Kirnbauer, and N. Hubbert, Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection, J Virol, vol.69, issue.6, pp.3959-63, 1995.

A. Rowhani-rahbar, C. Mao, and J. Hughes, Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. Vaccine Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions. Hum Vaccin, pp.5612-5621, 2007.

M. Molano, H. Posso, and E. Weiderpass, Prevalence and determinants of HPV infection among Colombian women with normal cytology, British Journal of Cancer, vol.189, issue.1, pp.324-357, 2002.
DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

R. Apple, H. Erlich, W. Klitz, M. Manos, T. Becker et al., HLA DR???DQ associations with cervical carcinoma show papillomavirus???type specificity, Nature Genetics, vol.40, issue.2, pp.157-62, 1994.
DOI : 10.1111/1523-1747.ep12281115

I. Kohaar, S. Hussain, and N. Thakur, Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women, Human Immunology, vol.70, issue.4, pp.222-231, 2009.
DOI : 10.1016/j.humimm.2009.01.003

S. Wang, P. Gonzalez, and K. Yu, Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer, PLoS ONE, vol.5, issue.1, p.8667
DOI : 10.1371/journal.pone.0008667.s005

URL : https://doi.org/10.1371/journal.pone.0008667

N. Munoz, F. Mendez, and H. Posso, Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results, The Journal of Infectious Diseases, vol.190, issue.12, pp.2077-87, 2004.
DOI : 10.1086/425907

A. Beby-defaux, I. Dichamp, and G. Agius, Biologie Clinique. 96, Papillomavirus humains. EMC, 2008.

C. Bergeron, J. Boulanger, and J. Levêque, Recommandations pour la prévention du cancer du col de l'utérus. CNGOF, 2007.

. Www, has-sante.fr/portail/jcms/c_592461/fiche-bum-gardasil Accessed, 2007.

J. Monsonego, Dysplasies du col utérin et papillomavirus humains, 1988.